|
1
|
Daly AF, Rixhon M, Adam C, Dempegioti A,
Tichomirowa MA and Beckers A: High prevalence of pituitary
adenomas: A cross-sectional study in the province of Liege,
Belgium. J Clin Endocrinol Metab. 91:4769–4775. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lieb JM and Ahlhelm FJ: Tumors of the
sellar region. Radiologe. 57:740–747. 2017.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stacey RJ and Powell MP: Sellar and
Parasellar Tumors. Neurosurgery. 187–204. 2006.PubMed/NCBI
|
|
4
|
Scheithauer BW, Horvath E, Kovacs K, Laws
ER Jr, Randall RV and Ryan N: Plurihormonal pituitary adenomas.
Semin Diagn Pathol. 3:69–82. 1986.PubMed/NCBI
|
|
5
|
Shah S, Waldman AD and Mehta A: Advances
in pituitary imaging technology and future prospects. Best Pract
Res Clin Endocrinol Metab. 26:35–46. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rand T, Lippitz P, Kink E, Huber H,
Schneider B, Imhof H and Trattnig S: Evaluation of pituitary
microadenom as with dynamic MR imaging. Eur J Radiol. 41:131–135.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kopczak A, Renner U and Karl Stalla G:
Advances in understanding pituitary tumors. F1000Prime Rep.
6:52014. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Murase K: Efficient method for calculating
kinetic parameters using T1-weighted dynamic contrast-enhanced
magnetic resonance imaging. Magn Reson Med. 51:858–862. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yankeelov TE, Lepage M, Chakravarthy A,
Broome EE, Niermann KJ, Kelley MC, Meszoely I, Mayer IA, Herman CR,
McManus K, et al: Integration of quantitative DCE-MRI and ADC
mapping to monitor treatment response in human breast cancer:
Initial results. Magn Reson Imaging. 25:1–13. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhijun Z: Research of DCE-MRI quantitative
analysis value in cervical squamous cell carcinomas microvascular
permeability. Chin J CT MRI. 13:71–73. 2015.(In Chinese).
|
|
11
|
Lei J, Tian Y, Zhu SC, Han Q, Wei Y, Yang
S and Shi DP: Preliminary study of IVIM-DWI and DCE-MRI in early
diagnosis of esophageal cancer. Eur Rev Med Pharmacol Sci.
19:3345–3350. 2015.PubMed/NCBI
|
|
12
|
Zhao LY, Zhou CW, Zhang RZ, et al:
Correlation of quantitative parameters of dynamic contrast-enhanced
MRI with subtypes of breast carcinoma. Chin J Med Imaging Technol.
29:1126–1130. 2013.(In Chinese).
|
|
13
|
Zhao J, Yang ZY, Luo BN, Yang JY and Chu
JP: Quantitative evaluation of diffusion and dynamic
contrast-enhanced MR in tumor parenchyma and peritumoral area for
distinction of brain tumors. PLoS One. 10:e01385732015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yuan A, Lin CY, Chou CH, Shih CM, Chen CY,
Cheng HW, Chen YF, Chen JJ, Chen JH, et al: Functional and
structural characteristics of tumor angiogenesis in lung cancers
overexpressing different VEGF isoforms assessed by DCE- and
SSCE-MRI. PLoS One. 6:e160622011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jia ZZ, Geng DY, Liu Y, Chen XR and Zhang
J: Microvascular permeability of brain astrocytoma with
contrast-enhanced magnetic resonance imaging: Correlation analysis
with histopathologic grade. Chin Med J (Engl). 126:1953–1956.
2013.PubMed/NCBI
|
|
16
|
Jia ZZ, Gu HM, Zhou XJ, Shi JL, Li MD,
Zhou GF and Wu XH: The assessment of immature microvascular density
in brain gliomas with dynamic contrast-enhanced magnetic resonance
imaging. Eur J Radiol. 84:1805–1809. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takada K, Yamada S and Teramoto A:
Correlation between tumor vascularity and clinical findings in
patients with pituitary adenomas. Endocr Pathol. 15:131–139. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lloyd RV, Scheithauer BW, Kuroki T, Vidal
S, Kovacs K and Stefaneanu L: Vascular endothelial growth factor
(VEGF) expression in human pituitary adenomas and carcinomas.
Endocr Pathol. 10:229–235. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tofts PS: Modeling tracer kinetics in
dynamic Gd-DTPA MR imaging. J Magn Reson Imaging. 7:91–101. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ruimin L, Yajia G, Jian M, et al: Research
of benign and malignant breast lesions differentiation using
quantitative DCE-MRI. Chin J Radiol. 45:164–169. 2011.(In
Chinese).
|
|
21
|
Wang Y, Huang W, Panicek DM, Schwartz LH
and Koutcher JA: Feasibility of using limited population-based
arterial input function for pharmacokinetic modeling of
osteosarcoma dynamic contrast-enhanced MRI data. Magn Reson Med.
59:1183–1189. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yankeelov TE, Cmn GO, Addison CL, Wallace
JC, Wilkins RC, Pappas BA, Santyr GE and Gore JC: Comparison of a
reference region model with direct measurement of an AIF in the
analysis of DCE-MRI data. Magn Reson Med. 57:353–361. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vidal S, Kovacs K, Horvath E, Scheithauer
BW, Kuroki T and Lloyd RV: Microvessel density in pituitary
adenomas and carcinomas. Virchows Arch. 438:595–602. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Turner HE, Nagy Z, Gatter KC, Esiri MM,
Harris AL and Wass JA: Angiogenesis in pituitary
adenomas-relationship to endocrine function, treatment and outcome.
J Endocrinol. 165:475–481. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Onguru O, Casey MB, Kajita S, Nakamura N
and Lloyd RV: Cyclooxygenase-2 and thromboxane synthase in
non-endocrine and endocrine tumors: A review. Endocr Pathol.
16:253–277. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Turner HE, Nagy Z, Gatter KC, Esiri MM,
Harris AL and Wass JA: Angiogenesis in pituitary adenomas and the
normal pituitary gland. J Clin Endocrinol Metab. 85:1159–1162.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jugenburg M, Kovacs K, Stefaneanu L and
Scheithauer BW: Vasculature in nontumorous hypophyses, pituitary
adenomas, and carcinomas: A quantitative morphological study.
Endocr Pathol. 6:115–124. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jasek E, Furgal-Borzych A, Lis GJ, Litwin
JA, Rzepecka-Wozniak E and Trela F: Microvessel density and area in
pituitary microadenomas. Endocr Pathol. 20:221–226. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jeffcoate WJ, Pound N, Sturrock ND and
Lambourne J: Long-term follow-up of patients with
hyperprolactinaemia. Clin Endocrinol (Oxf). 45:299–303. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Juneau P, Schoene W C and Black P:
Malignant tumors in the pituitary gland. Arch Neurol. 49:555–558.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lidhar K, Korbonits M, Jordan S, Khalimova
Z, Kaltsas G, Lu X, Clayton RN, Jenkins PJ, Monson JP, Besser GM,
et al: Low expression of the cell cycle inhibitor p27Kip1 in normal
corticotroph cells, corticotroph tumors, and malignant pituitary
tumors. J Clin Endocrinol Metab. 84:3823–3830. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lohrer P, Gloddek J, Hopfner U, Losa M,
Uhl E, Pagotto U, Stalla GK and Renner U: Vascular endothelial
growth factor production and regulation in rodent and human
pituitary tumor cells in vitro. Neuroendocrinology. 74:95–105.
2001. View Article : Google Scholar : PubMed/NCBI
|
